MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
J15 · Effective Apr 17, 2022
11 active Medicare policies list 87475, and 4 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Apr 17, 2022
JE · Effective Apr 17, 2022
JF · Effective Apr 17, 2022
JJ · Effective Apr 17, 2022
JM · Effective Apr 17, 2022
J5 · Effective Apr 17, 2022
J8 · Effective Apr 17, 2022
National · Effective Mar 19, 2026
4 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 87475 |
|---|---|---|
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 87475 |
|---|---|---|
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |
| Policy | Effective | Status of 87475 |
|---|---|---|
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease |
National · Effective Mar 19, 2026
National · Effective Apr 16, 2026
J5 · Effective Mar 12, 2026
| Dec 15, 2025 |
| Covered |
| Policy | Effective | Status of 87475 |
|---|---|---|
| Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | Dec 15, 2025 | Covered |